Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jing Christine Ye

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2024
Optical Genome Mapping: A Machine-Based Platform in CytogenomicsJing Christine Ye, Guilin Tang
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2024
Tracking Karyotype Changes in Treatment-Induced Drug-Resistant EvolutionJing Christine Ye, Henry H Heng
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2024
The New Era of Cancer Cytogenetics and CytogenomicsJing Christine Ye, Henry H Heng
Genes|February 27, 2026
Conversation with Future Clinical Cytogeneticists: The New FrontiersJing Christine Ye, Rishi Chowdhury, Henry H Heng
Frontiers in Cell and Developmental Biology|July 1, 2021
Therapy Induced Genome Chaos: A Novel Mechanism of Rapid Cancer Drug ResistanceJing Christine Ye, Steve Horne, Jack Z Zhang, et al.
Biomarker Research|May 18, 2022
The role of biomarkers in personalized immunotherapyKamya Sankar, Jing Christine Ye, Zihai Li, et al.
Cancer Letters|February 28, 2026
Therapy-induced rapid drug resistance driven by genome chaos and polyploid giant cancer cellsSteven D Horne, Jing Christine Ye, Guo Liu, et al.
Journal of Hematology & Oncology|April 21, 2021
Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meetingJing-Zhou Hou, Jing Christine Ye, Jeffrey J Pu, et al.
Leukemia & Lymphoma|November 20, 2019
Optimal sequence of daratumumab and elotuzumab in relapsed and refractory multiple myelomaEmily Hoylman, Anna Brown, Anthony J Perissinotti, et al.
American Journal of Hematology|December 30, 2025
Extramedullary Disease-Achilles Heel in Myeloma?Shaji Kumar, Joshua Richter, Saad Z Usmani, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2024
Optical Genome Mapping: A Machine-Based Platform in CytogenomicsJing Christine Ye, Guilin Tang
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2024
Tracking Karyotype Changes in Treatment-Induced Drug-Resistant EvolutionJing Christine Ye, Henry H Heng
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2024
The New Era of Cancer Cytogenetics and CytogenomicsJing Christine Ye, Henry H Heng
Genes|February 27, 2026
Conversation with Future Clinical Cytogeneticists: The New FrontiersJing Christine Ye, Rishi Chowdhury, Henry H Heng
Frontiers in Cell and Developmental Biology|July 1, 2021
Therapy Induced Genome Chaos: A Novel Mechanism of Rapid Cancer Drug ResistanceJing Christine Ye, Steve Horne, Jack Z Zhang, et al.
Biomarker Research|May 18, 2022
The role of biomarkers in personalized immunotherapyKamya Sankar, Jing Christine Ye, Zihai Li, et al.
Cancer Letters|February 28, 2026
Therapy-induced rapid drug resistance driven by genome chaos and polyploid giant cancer cellsSteven D Horne, Jing Christine Ye, Guo Liu, et al.
Journal of Hematology & Oncology|April 21, 2021
Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meetingJing-Zhou Hou, Jing Christine Ye, Jeffrey J Pu, et al.
Leukemia & Lymphoma|November 20, 2019
Optimal sequence of daratumumab and elotuzumab in relapsed and refractory multiple myelomaEmily Hoylman, Anna Brown, Anthony J Perissinotti, et al.
American Journal of Hematology|December 30, 2025
Extramedullary Disease-Achilles Heel in Myeloma?Shaji Kumar, Joshua Richter, Saad Z Usmani, et al.
Pageof 3